Sagimet Biosciences Inc. (SGMT)
(Delayed Data from NSDQ)
$6.92 USD
-0.42 (-5.72%)
Updated Sep 29, 2025 04:00 PM ET
After-Market: $6.90 -0.02 (-0.29%) 6:44 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SGMT 6.92 -0.42(-5.72%)
Will SGMT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SGMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGMT
Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks
Sagimet Biosciences Inc. (SGMT) Upgraded to Buy: What Does It Mean for the Stock?
SGMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now?
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know
Other News for SGMT
Stochastic Reached Overbought appears for SGMT after 2.8% move
Technical picture remains unchanged for SGMT after it falls 1.92% on September 26
Crossed Above 20 Day Moving Average appears for SGMT after 8.17% move
SGMT forms 20 Day Moving Average Resistance on September 24
Is SGMT set to rally? MACD Bullish Signal Line Cross shows up after climbing 4.45%